| scholarly article | Q13442814 |
| P50 | author | Yves Pommier | Q28320644 |
| Ettore Novellino | Q38359645 | ||
| Luciana Marinelli | Q39061698 | ||
| Sandro Cosconati | Q39061714 | ||
| Silvia Salerno | Q46615312 | ||
| Anna Maria Marini | Q46615325 | ||
| Francesco Saverio Di Leva | Q52585400 | ||
| Roberto Di Santo | Q54667214 | ||
| Concettina La Motta | Q56550100 | ||
| Sabrina Taliani | Q57119654 | ||
| Christophe H Marchand | Q57421220 | ||
| Elisabetta Barresi | Q58863181 | ||
| Federico Da Settimo Passetti | Q58982862 | ||
| Francesca Simorini | Q61037557 | ||
| Isabella Pugliesi | Q114517382 | ||
| P2093 | author name string | Keli Agama | |
| P2860 | cites work | Cellular roles of dna topoisomerases: a molecular perspective | Q22121990 |
| Drugging topoisomerases: lessons and challenges | Q27000099 | ||
| Nonlinear partial differential equations and applications: The mechanism of topoisomerase I poisoning by a camptothecin analog | Q27639935 | ||
| Cellular Topoisomerase I Inhibition and Antiproliferative Activity by MJ-III-65 (NSC 706744), an Indenoisoquinoline Topoisomerase I Poison | Q29394250 | ||
| DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition | Q29400901 | ||
| A semiempirical free energy force field with charge-based desolvation | Q29614316 | ||
| Topoisomerase I inhibitors: camptothecins and beyond | Q29614976 | ||
| One-pot microwave assisted preparation of pyrazoloquinazolinone libraries | Q33197880 | ||
| Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins. | Q34564807 | ||
| Repair of topoisomerase I-mediated DNA damage | Q36557533 | ||
| Targeting DNA topoisomerase I with non-camptothecin poisons. | Q37971946 | ||
| Dialkylaminoalkylindolonaphthyridines as potential antitumour agents: synthesis, cytotoxicity and DNA binding properties | Q40707457 | ||
| A force field with discrete displaceable waters and desolvation entropy for hydrated ligand docking | Q42557837 | ||
| Differential induction of topoisomerase I-DNA cleavage complexes by the indenoisoquinoline MJ-III-65 (NSC 706744) and camptothecin: base sequence analysis and activity against camptothecin-resistant topoisomerases I | Q44652194 | ||
| Benzothiopyranoindole-Based Antiproliferative Agents: Synthesis, Cytotoxicity, Nucleic Acids Interaction, and Topoisomerases Inhibition Properties | Q58855736 | ||
| The structural basis of camptothecin interactions with human serum albumin: impact on drug stability | Q72726302 | ||
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 7458-7462 | |
| P577 | publication date | 2013-09-16 | |
| P1433 | published in | Journal of Medicinal Chemistry | Q900316 |
| P1476 | title | Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of noncamptothecin topoisomerase I (Top1) inhibitors | |
| P478 | volume | 56 |
| Q93166626 | Discovery of Pyrido[3',2':5,6]thiopyrano[4,3-d]pyrimidine-Based Antiproliferative Multikinase Inhibitors |
| Q38882751 | Discovery of potent indenoisoquinoline topoisomerase I poisons lacking the 3-nitro toxicophore |
| Q48271013 | Pyrazolo[1,5-a]quinazoline scaffold as 5-deaza analogue of pyrazolo[5,1-c][1,2,4]benzotriazine system: synthesis of new derivatives, biological activity on GABAA receptor subtype and molecular dynamic study. |
| Q57062310 | Synthesis and cytotoxic evaluation of novel quinazolinone derivatives as potential anticancer agents |
| Q64939460 | Synthesis and cytotoxic evaluation of novel quinozalinone derivatives with substituted benzimidazole in position 3. |
Search more.